about
Structural insight into the complex formation of latent matrix metalloproteinase 2 with tissue inhibitor of metalloproteinase 2.Structure of human pro-matrix metalloproteinase-2: activation mechanism revealedStructural insights into the adaptation of proliferating cell nuclear antigen (PCNA) fromHaloferax volcaniito a high-salt environmentAn intact eight-membered water chain in drosophilid alcohol dehydrogenases is essential for optimal enzyme activityDNA-dependent formation of transcription factor pairs alters their binding specificityThe atomic structure of Carnation Mottle Virus capsid proteinThree-dimensional structure of human tissue inhibitor of metalloproteinases-2 at 2.1 A resolutionConservation of transcription factor binding specificities across 600 million years of bilateria evolutionDNA-binding specificities of human transcription factorsVirtual screening, selection and development of a benzindolone structural scaffold for inhibition of lumazine synthaseImpact of cytosine methylation on DNA binding specificities of human transcription factors.Characterization of recombinant soluble macrophage scavenger receptor MARCO.Characterization of the interactions of the nephrin intracellular domain.Novel mutation in Wilms' tumour 1 gene associated with steroid-resistant nephrotic syndromeStructural insights into the DNA-binding specificity of E2F family transcription factorsLoss of SUFU function in familial multiple meningioma.Isolation, crystallization and preliminary crystallographic analysis of Salmonella typhimurium uridine phosphorylase crystallized with 2,2'-anhydrouridineX-ray structural studies of the fungal laccase from Cerrena maxima.Two distinct DNA sequences recognized by transcription factors represent enthalpy and entropy optima.Impact of constitutional TET2 haploinsufficiency on molecular and clinical phenotype in humansNew approaches to chromatographic purification of bovine dopamine-beta-hydroxylaseStructural and thermodynamic insights into the binding mode of five novel inhibitors of lumazine synthase from Mycobacterium tuberculosis
P50
Q24530532-AA1AF48F-0940-4AFD-87DE-0CED8EFF00F9Q27618464-C3FCE844-DB88-439E-878A-BDFAA81D11B1Q27657512-B4017BBD-6C6C-4276-8AD2-12865FD1314DQ27681631-EA3710F5-F6E1-484E-9BD2-095FB940EE18Q27702589-46B5D328-1055-489C-AAE7-0CD03E259F8EQ27731563-344E3F2A-6EF0-4DC2-A954-1689349959C7Q27766109-0F581418-0814-482F-83F9-D5A34F8FE9FCQ28652295-A44A5203-997D-4FE2-8BFC-621D9C4E6BBDQ28854562-0CB0A191-E27B-410C-9598-CEDB1797F8D1Q30494491-81173B23-E1E5-4047-AA9A-838A1B86B379Q31814782-B2838927-27FA-4EDB-A8E8-D70B1001F13BQ34136893-32BD98EC-021E-43AC-BE36-F8A2B4E954F5Q34553954-B5555109-0D09-460D-AB6A-05257F50F9FCQ35574424-4F8A7EE6-09B3-4B8E-8044-AD2EE43B1A8DQ36392339-44AF43B9-6AE3-45A5-ABD1-DB464ED1F6E5Q36439334-47D9BC83-9AB4-46B8-9B1B-4A7247858AE9Q41814799-67CD735B-0F73-40DA-8979-37075069AC7FQ50476199-1B79E9A1-9937-4FDC-A8C1-A69441FE1E53Q52381597-BB23CBC5-2D40-47DB-B9DD-1E53C0F3DBCDQ64039792-D3147CBE-0C02-4063-86C2-958545947B47Q71579401-1BF939B7-51ED-48CD-ABB3-ED9262F29045Q80290686-A3D5386F-CFF4-47A8-B40E-E8CDB1CAA0CF
P50
description
researcher, ORCID id # 0000-0002-7754-9021
@en
wetenschapper
@nl
name
Ekaterina Morgunova
@ast
Ekaterina Morgunova
@en
Ekaterina Morgunova
@es
Ekaterina Morgunova
@nl
type
label
Ekaterina Morgunova
@ast
Ekaterina Morgunova
@en
Ekaterina Morgunova
@es
Ekaterina Morgunova
@nl
prefLabel
Ekaterina Morgunova
@ast
Ekaterina Morgunova
@en
Ekaterina Morgunova
@es
Ekaterina Morgunova
@nl
P106
P31
P496
0000-0002-7754-9021